Efficacy News and Research

RSS
Yeast-derived polysaccharide mixture effectively inhibits the onset, progression of immune disorders

Yeast-derived polysaccharide mixture effectively inhibits the onset, progression of immune disorders

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Novel biosensor offers rapid quantitative variant of concern-independent serology for SARS-CoV-2

Study examines safety of COVID-19 vaccination during lactation

Study examines safety of COVID-19 vaccination during lactation

Pronation maneuvers for critically ill COVID-19 patients - multidisciplinary management reduce complications

Pronation maneuvers for critically ill COVID-19 patients - multidisciplinary management reduce complications

Mask-wearing reduces COVID-19 transmission significantly, study finds

Mask-wearing reduces COVID-19 transmission significantly, study finds

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

Could polio vaccines induce cross-reactive antibodies that target SARS-CoV-2?

New tablet-sized device can profile multiple COVID-19 antibodies and biomarkers simultaneously

New tablet-sized device can profile multiple COVID-19 antibodies and biomarkers simultaneously

Bivalent DNA SARS-CoV-2 vaccine induces strong humoral and cellular immunity in mice

Bivalent DNA SARS-CoV-2 vaccine induces strong humoral and cellular immunity in mice

Study finds no evidence for remdesivir's benefit in severe COVID-19 patients

Study finds no evidence for remdesivir's benefit in severe COVID-19 patients

SARS-CoV-2 Delta variant likely to become dominant in the United States

SARS-CoV-2 Delta variant likely to become dominant in the United States

Cedars-Sinai receives $11.99 million from CIRM to launch ALS clinical trial

Cedars-Sinai receives $11.99 million from CIRM to launch ALS clinical trial

SARS-CoV-2 infection and transmission in the North American deer mouse

SARS-CoV-2 infection and transmission in the North American deer mouse

Indian SARS-CoV-2 variant has unique infection and immune escape strategy say researchers

Indian SARS-CoV-2 variant has unique infection and immune escape strategy say researchers

Natural compound myricetin shows antiviral potential against SARS-CoV-2

Natural compound myricetin shows antiviral potential against SARS-CoV-2

Higher levels of antibodies from COVID-19 mRNA vaccine compared to natural SARS-CoV-2 infection

Higher levels of antibodies from COVID-19 mRNA vaccine compared to natural SARS-CoV-2 infection

Vaccine side effects should be viewed as a sign of efficacy, say immunologists

Vaccine side effects should be viewed as a sign of efficacy, say immunologists

University Hospitals in Northeast Ohio performs first innovative heart procedure

University Hospitals in Northeast Ohio performs first innovative heart procedure

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

Cancer immunotherapy may self-limit its efficacy in fighting tumors, study finds

Cancer immunotherapy may self-limit its efficacy in fighting tumors, study finds

New antibody-drug conjugates also kill non-targeted neighboring tumor cells

New antibody-drug conjugates also kill non-targeted neighboring tumor cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.